[To the Editor---]{.smallcaps}On April 27, 2020, the Paediatric Intensive Care Society of the United Kingdom reported cases of critically ill children presenting with features of Kawasaki disease or toxic shock syndrome, associated with coronavirus disease 2019 (COVID-19). Subsequent case definitions for the multisystem inflammatory syndrome in children associated with COVID-19 have been released \[[@CIT0001], [@CIT0002]\]. New York City (NYC) has had the largest burden of COVID-19 cases in the United States, with the Bronx borough experiencing the highest rate of infections (2766 per 100 000) \[[@CIT0003]\]. Our initial clinical experience of mostly mild COVID-19 illness in children changed with the presentation of children with systemic inflammation and cardiac involvement, all of whom tested negative at presentation for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by polymerase chain reaction (PCR), with subsequent positive antibody testing. We present 4 patients who presented over a 2-week period (April 26--May 11, 2020).

All patients had fever, and 3 patients (patients 1, 2, and 4) presented with gastrointestinal symptoms and tachycardia ([Table 1](#T1){ref-type="table"}). None had respiratory symptoms or features of Kawasaki disease. Only one had a known contact with a confirmed COVID-19 case. Laboratory investigations showed signs of systemic inflammation with increased levels of C-reactive protein and ferritin, but normal procalcitonin levels. Peripheral white blood cell counts revealed lymphopenia in all patients. All had elevated troponin and pro--brain natriuretic peptide levels. Two patients (patients 2 and 3) had features of clinical myocarditis (markedly elevated troponin and decreased ejection fraction on echocardiography). All patients were transferred to pediatric cardiac centers. Patient 1 developed refractory vasoplegic shock on his second day of admission, necessitating transfer for mechanical circulatory support. Patient 2 was also transferred for mechanical circulatory support in the setting of severely depressed myocardial function. After the learned experience of rapid clinical deterioration, subsequent patients presenting to our emergency department with high suspicion of COVID-19 have had prompt cardiac investigations with electrocardiography and cardiac biomarkers.

###### 

Clinical Presentation, Laboratory and Cardiac Investigations, and Outcomes of Pediatric Patients With Systemic Inflammation, Cardiac Involvement, and Evidence of COVID-19 Presenting at a Bronx Community Hospital, April 26-May 11, 2020

  Characteristic                     Patient 1                                                                                                                    Patient 2                                                                                                            Patient 3                                                                                                 Patient 4
  ---------------------------------- ---------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------
  Date of presentation               April 26, 2020                                                                                                               April 29, 2020                                                                                                       May 9, 2020                                                                                               May 11, 2020
  Age                                5 years                                                                                                                      20 years                                                                                                             17 years                                                                                                  3 years
  Sex                                Male                                                                                                                         Male                                                                                                                 Male                                                                                                      Female
  Presenting symptoms                Abdominal pain and fever × 3 days                                                                                            Fever × 2 days, neck pain, vomiting, diarrhea                                                                        Chest pain (fever several days prior which resolved before presentation)                                  Fever × 6 days, diarrhea
  Known COVID-19 contact             Yes                                                                                                                          No                                                                                                                   No                                                                                                        No
  SARS-CoV-2 rtPCR^a^                Negative                                                                                                                     Negative                                                                                                             Negative (positive at OSH)                                                                                Negative
  SARS-CoV-2 IgG^b^                  Positive                                                                                                                     Positive                                                                                                             Positive                                                                                                  Positive
  CRP, mg/L (\<5)                    117→280                                                                                                                      257                                                                                                                  53                                                                                                        390
  Procalcitonin, ng/mL (0.02--100)   4                                                                                                                            2.25                                                                                                                 0.18                                                                                                      Not done
  WBC count, 1000/μL                 6.2                                                                                                                          7.1                                                                                                                  9.2                                                                                                       17.2
  Neutrophils, %                     84                                                                                                                           88                                                                                                                   75                                                                                                        82
  Lymphocytes, %                     11                                                                                                                           5                                                                                                                    10                                                                                                        7
  Hemoglobin, g/dL                   12.5                                                                                                                         11.3                                                                                                                 15.8                                                                                                      9.9
  Platelets, 1000/μL                 186 → 89                                                                                                                     82                                                                                                                   289                                                                                                       426
  Troponin T, ng/L (\<12)            27                                                                                                                           123 → 293                                                                                                            1084→1771                                                                                                 21
  pro-BNP, pg/mL (0--125)            24 604                                                                                                                       1780                                                                                                                 97→324                                                                                                    14 127
  AST, U/L (9--51)                   WNL                                                                                                                          WNL                                                                                                                  104                                                                                                       WNL
  ALT, U/L (5--40)                   WNL                                                                                                                          WNL                                                                                                                  27                                                                                                        WNL
  D-dimer, ng/mL (0--230)            793→9187                                                                                                                     521                                                                                                                  \<50                                                                                                      817
  Fibrinogen, mg/dL (185--450)       328                                                                                                                          836                                                                                                                  753                                                                                                       Not done
  Ferritin, ng/mL (13--150)          395→840                                                                                                                      411                                                                                                                  153                                                                                                       355
  PT, sec (10.7--12.9)               16.8                                                                                                                         22.1                                                                                                                 12.1                                                                                                      16
  INR (0.9--1.09)                    1.4                                                                                                                          1.84                                                                                                                 1.02                                                                                                      1.34
  Electrocardiogram                  Sinus tachycardia, low voltages, nonspecific T-wave abnormality                                                              Sinus tachycardia, rightward axis                                                                                    Normal sinus rhythm → developed inferior ST segment elevation                                             Sinus tachycardia, nonspecific T-wave abnormality, borderline QTc prolongation
  Echocardiography^c^                Moderate MR. Mildly depressed LV function (LV EF 48.1%). Small pericardial effusion. Moderate bilateral pleural effusions.   Mild TR. Mildly depressed RV function. Severely depressed LV function (LV EF 32%).                                   OSH: Mildly depressed LV function (LV EF 44%). No coronary artery abnormalities.                          Mild TR, mild MR, mildly depressed LV function (LV EF 46.9%). No coronary artery abnormalities.
  Outcome                            Developed vasoplegic shock. Transferred. OSH: ECMO, died due to catastrophic ICH and herniation.                             Transferred. OSH: vasopressors, IABP, intubated. convalescent plasma. EF 50% at discharge. Discharged on apixaban.   Transferred. OSH: IVIG. No pressors or intubation. Normal function at discharge. Discharged on lovenox.   Transferred. OSH: IVIG, tocilizumab × 2. Normal function at discharge. Discharged on lovenox.

Normal range in parentheses.

Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; BNP, brain natriuretic peptide; COVID-19, coronavirus disease 2019; CRP, C-reactive protein; ECMO, extracorporeal membrane oxygenation; EF, ejection fraction; IABP, intraaortic balloon pump; ICH, intracranial hemorrhage; IgG, immunoglobulin G; INR, international normalized ratio; IVIG, intravenous immunoglobulin; LV, left ventricle; MR, mitral regurgitation; OSH, outside hospital; PT, prothrombin time; rtPCR, real-time polymerase chain reaction; RV, right ventricle; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; TR, tricuspid regurgitation; WBC, white blood cell; WNL, within normal limits.

^a^Cobas SARS-CoV-2 Test (Roche).

^b^Alinity i SARS-CoV-2 IgG (Abbott).

^c^Coronary artery assessments for patient 1 and 2 were not performed as they were clinically unstable at the time of initial cardiology assessment.

These cases highlight the challenge for physicians assessing pediatric patients presenting with symptoms of fever and gastrointestinal illness. In addition to the standard differential diagnoses of bacterial sepsis, gastroenteritis, and acute abdomen, multisystem inflammatory syndrome with myocardial involvement must also be considered, even with negative SARS-CoV-2 PCR results. We report a wide range of cardiac involvement in children with documented COVID-19, including valvulitis, myocarditis, and shock. We propose that in addition to simultaneous SARS-CoV-2 PCR and antibody testing, inflammatory markers, cardiac enzymes, and electrocardiography should be considered in lymphopenic pediatric patients presenting with fever, significant tachycardia, and gastrointestinal symptoms in areas with widespread community transmission of COVID-19. Prompt referral to an advanced pediatric cardiac center should be considered if myocardial involvement is suspected, as clinical deterioration can be rapid.
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